|
2025
|
Invention
|
Triterpene saponin analogues.
The present application relates to triterpene glycoside saponin-de... |
|
2023
|
Invention
|
Triterpene saponin synthesis, intermediates and adjuvant combinations.
The present application r... |
|
|
Invention
|
Triterpene saponin analogues. The present application relates to triterpene glycoside saponin-der... |
|
2022
|
Invention
|
Adjuvant compounds and formulations.
The present application relates to triterpene glycoside sap... |
|
|
Invention
|
Adjuvant compounds and formulations. The present application relates to triterpene glycoside sapo... |
|
|
Invention
|
Vaccines.
The present application relates to triterpene glycoside saponin-derived adjuvants, TLR... |
|
|
Invention
|
Vaccines. The present application relates to triterpene glycoside saponin-derived adjuvants, TLR4... |
|
2021
|
Invention
|
Vaccines, vaccine priming, and antigen dose sparing. The present application relates to new vacci... |
|
|
Invention
|
Adjuvant compounds, salt forms, and formulations. The present application relates to triterpene g... |
|
2020
|
Invention
|
Varicella zoster. The present application relates to compositions capable of inducing an immune r... |
|
2018
|
Invention
|
Triterpene saponin synthesis, intermediates and adjuvant combinations. The present application re... |
|
2016
|
Invention
|
Triterpene saponin analogues. The present application relates to triterpene glycoside sapon... |
